Table 2. Additional cost scenarios at launch.
Doses | Low income countries (LMICs) | Middle income countries (MICs) | |||||
---|---|---|---|---|---|---|---|
Per dose* | Implementation* | Total for Regimen* | Per dose* | Implementation* | Total* | ||
Launch scenarios | |||||||
Base | 3 | 5 | 5 | 20 | 15 | 10 | 55 |
Higher price | 3 | 10 | 5 | 35 | 30 | 10 | 100 |
Very high price | 3 | 20 | 5 | 65 | 50 | 10 | 160 |
Middle income price = lower income price | 3 | 5 | 5 | 20 | 5 | 5 | 20 |
2-dose regimen | 2 | 5 | 4 | 14 | 15 | 8 | 38 |
4-dose regimen | 4 | 5 | 6 | 26 | 15 | 12 | 72 |
10-years-out scenarios | |||||||
Base | 3 | 3 | 3 | 12 | 10 | 7 | 37 |
Higher price | 3 | 5 | 3 | 18 | 15 | 7 | 52 |
Very high price | 3 | 10 | 3 | 33 | 30 | 7 | 97 |
Middle income price = lower income price | 3 | 3 | 3 | 12 | 3 | 3 | 12 |
2-dose regimen | 2 | 3 | 2 | 8 | 10 | 5 | 25 |
4-dose regimen | 4 | 3 | 4 | 16 | 10 | 9 | 49 |
*Costs presented in US$.